Tretinoin (all-trans retinoic acid), CAS No. 302-79-4 is widely used in pharmaceutical, dermatological, and analytical research. This d6-labeled analog is designed to support LC-MS/MS method development, validation, and quantitative analysis where a robust internal standard is critical.
Previously available Tretinoin-d5 materials have demonstrated lower isotopic enrichment and residual unlabeled content, which can create potential interference challenges for end users. To overcome this, TLC developed a superior d6-labeled version by directly introducing six deuterium atoms onto two methyl groups using deuterated reagents, resulting in stronger label stability and improved analytical performance.
Our final product achieves:
- 99.5% deuterium enrichment
- No detectable d0 content
- Stable deuterium incorporation resistant to label loss during testing
- Improved suitability as an internal standard for sensitive LC-MS/MS applications
- COA available here: COA
The development of Tretinoin-d6 required a highly complex synthetic route involving more than 15 steps. Both intermediates and the final product are highly unstable and sensitive to light and temperature, requiring strict oxygen-free, light-free, and low-temperature conditions throughout reaction, workup, and purification processes.
Due to the technical difficulty of synthesis and the exceptional isotopic quality achieved, Tretinoin-d6 represents a significant advancement for laboratories requiring dependable SIL reference standards.
Please contact TLC for availability and quotation.